Ingrid Struman
Ingrid Struman
Verified email at
Cited by
Cited by
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy
D Hilfiker-Kleiner, K Kaminski, E Podewski, T Bonda, A Schaefer, K Sliwa, ...
Cell 128 (3), 589-600, 2007
Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study
K Sliwa, L Blauwet, K Tibazarwa, E Libhaber, JP Smedema, A Becker, ...
Circulation 121 (13), 1465-1473, 2010
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
J Halkein, SP Tabruyn, M Ricke-Hoch, A Haghikia, M Scherr, ...
The Journal of clinical investigation 123 (5), 2143-2154, 2013
Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis
I Struman, F Bentzien, H Lee, V Mainfroid, G D’Angelo, V Goffin, ...
Proceedings of the National Academy of Sciences 96 (4), 1246-1251, 1999
Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the …
G d'Angelo, I Struman, J Martial, RI Weiner
Proceedings of the National Academy of Sciences 92 (14), 6374-6378, 1995
MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells
C Sabatel, L Malvaux, N Bovy, C Deroanne, V Lambert, MLA Gonzalez, ...
PloS one 6 (2), e16979, 2011
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy
A Haghikia, E Podewski, E Libhaber, S Labidi, D Fischer, P Roentgen, ...
Basic research in cardiology 108 (4), 1-13, 2013
Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice
V Lambert, J Lecomte, S Hansen, S Blacher, MLA Gonzalez, I Struman, ...
Nature protocols 8 (11), 2197-2211, 2013
Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine
D Hilfiker-Kleiner, GP Meyer, E Schieffer, B Goldmann, E Podewski, ...
Journal of the American College of Cardiology 50 (24), 2354-2355, 2007
miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization
K Valencia, D Luis-Ravelo, N Bovy, I Antón, S Martínez-Canarias, ...
Molecular oncology 8 (3), 689-703, 2014
Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer
N Bovy, B Blomme, P Frères, S Dederen, O Nivelles, M Lion, O Carnet, ...
Oncotarget 6 (12), 10253, 2015
Zebrafish Sox7 and Sox18 function together to control arterial–venous identity
H Pendeville, M Winandy, I Manfroid, O Nivelles, P Motte, V Pasque, ...
Developmental biology 317 (2), 405-416, 2008
Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance
D Piwnica, P Touraine, I Struman, S Tabruyn, G Bolbach, C Clapp, ...
Molecular endocrinology 18 (10), 2522-2542, 2004
The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-κB
SP Tabruyn, CM Sorlet, F Rentier-Delrue, V Bours, RI Weiner, JA Martial, ...
Molecular Endocrinology 17 (9), 1815-1823, 2003
Evidence for a second receptor binding site on human prolactin.
V Goffin, I Struman, V Mainfroid, S Kinet, JA Martial
Journal of Biological Chemistry 269 (51), 32598-32606, 1994
The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation
JF Martini, C Piot, LM Humeau, I Struman, JA Martial, RI Weiner
Molecular Endocrinology 14 (10), 1536-1549, 2000
Inhibition of urokinase activity by the antiangiogenic factor 16K prolactin: activation of plasminogen activator inhibitor 1 expression
H Lee, I Struman, C Clapp, J Martial, RI Weiner
Endocrinology 139 (9), 3696-3703, 1998
Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase
B Detry, C Erpicum, J Paupert, S Blacher, C Maillard, F Bruyère, ...
Blood, The Journal of the American Society of Hematology 119 (21), 5048-5056, 2012
PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin
K Bajou, S Herkenne, VL Thijssen, S D'amico, A Bouche, S Tabruyn, ...
Nature medicine 20 (7), 741-747, 2014
The Antiangiogenic Factor, 16-kDa Human Prolactin, Induces Endothelial Cell Cycle Arrest by Acting at Both the G0–G1 and the G2–M Phases
SP Tabruyn, NQN Nguyen, AM Cornet, JA Martial, I Struman
Molecular Endocrinology 19 (7), 1932-1942, 2005
The system can't perform the operation now. Try again later.
Articles 1–20